Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
60 results (top 60)
- 1/2상모집 중· Arthritis, Rheumatoid난치성 류마티스 관절염 환자를 대상으로 한 BMS-986528 연구
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
리드: BMS
- 1/2상모집 중· Hemophilia A중증 또는 중등도 중증 혈우병 A 성인 환자를 대상으로 한 SPK-8011QQ 유전자 치료 연구
A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
리드: 로슈
- 1/2상모집 중· Healthy Volunteers18세 이상 건강한 성인에서 Matrix-M 보강 난황 기반 H5N8 인플루엔자 백신의 안전성 및 면역원성 평가
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
리드: 사노피
- 1/2상모집 중· Relapsed or Refractory Multiple Myeloma재발성 또는 불응성 다발성골수종 환자에서 AZD4045를 평가하는 모듈식 1/2상 다기관 연구
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
리드: 아스트라제네카
- 1/2상모집 중· Respiratory Syncytial Virus Immunization60세 이상 성인에서 호흡기세포융합바이러스 및 인간 메타뉴모바이러스(RSV+HMPV) 백신 후보 물질 1/2상 연구
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
리드: 사노피
- 1/2상모집 중· Metastatic Castration-Resistant Prostate Cancer (mCRPC)전이성 거세 저항성 전립선암 및 투명세포 신장세포암종 환자에서 REGN15505(PSMAx4-1BB) 단독 또는 Cemiplimab 또는 REGN4336(PSMAxCD3)과의 병용
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
리드: 리제네론
- 1/2상모집 중· HER2+ Metastatic Breast CancerHER2+ 유방암 뇌전이에서의 아스시미닙
Asciminib in HER2+ Breast Cancer Brain Metastases
협력: 노바티스
- 1/2상모집 중· Malignant Neoplasm재발 또는 난치성 고형종양 소아 참가자를 대상으로 한 이피나타맙 데럭스테칸 임상시험(MK-9999-01D/LIGHTBEAM-U01)
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
리드: 머크(MSD)
- 1/2상모집 중· Acute Lymphoblastic Leukemia재발/불응성 필라델피아 양성 또는 ABL계 필라델피아 유사 급성 림프모구백혈병 소아 청년에서 아시미니브의 안전성 및 효능
Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
리드: 노바티스
- 1/2상모집 중· Rheumatoid Arthritis성인 류마티스관절염 환자에서 정맥 사릴루맙의 1b/2상 연구
Phase 1b/2 Study of IV Sarilumab in Adult With RA
리드: 사노피 · 협력: 리제네론
- 1/2상모집 중· SCHIZOPHRENIA 1 (Disorder)조현병에서 코벤피의 도파민 전달에 대한 PET/MRI 연구
A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
협력: BMS
- 1/2상모집 중· Aplastic Anemia불응성 중증 재생불량빈혈에서 항CD38 단일클론항체의 I/II상 임상시험
Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic Anemia
협력: 사노피
- 1/2상모집 중· Hepatitis CC형간염(HIV 동반 여부 상관없음) 임신 여성에서 글레카프레비르/피브렌타스비르의 약동학 및 안전성 연구
Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV
협력: 애브비
- 1/2상모집 중· Malignant Neoplasm일본 소아 고형암·림프종 및 성인 머클세포암종 환자를 대상으로 하는 펨브롤리주맙 연구 (MK-3475-G21/KEYNOTE-G21)
A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)
리드: 머크(MSD)
- 1/2상모집 중· Sarcoma진행성 육종 환자에서 리스부타투그 레제테칸의 유효성 및 안전성 평가 연구 (EMBOLD Sarcoma-202)
A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
리드: GSK
- 1/2상모집 중· Extensive-stage Small Cell Lung Cancer (ES-SCLC)DLL3 표적 CAR-T 치료제 DJI136 평가 연구
A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy
리드: 노바티스
- 1/2상모집 중· Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer오프누라시브 단독 또는 병용 투여 지속 롤오버 연구
Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments
리드: 노바티스
- 1/2상모집 중· Respiratory Syncytial Virus Infections+Metapneumovirus젊은 성인과 노년 성인에서 시험용 RSV/hMPV 조합 및 hMPV 백신 연구
A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults
리드: GSK
- 1/2상모집 중· Advanced Solid TumorKRAS 돌연변이 진행성 고형 종양에서 BLU-924의 초기 인체 임상시험
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
협력: 사노피
- 1/2상모집 중· Metastatic Prostate Cancer전이성 전립선암 환자에서 여러 항암제의 1b/2상 플랫폼 연구
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
리드: 아스트라제네카
- 1/2상모집 중· Relapse Multiple Myeloma재발 및/또는 불응성 다발성 골수종 환자를 위한 셀리넥서, 카르필조닙, 이사튁시맙, 덱사메타손 병용 연구
Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma
협력: 사노피
- 1/2상모집 중· Metastatic Prostate Cancer전립선암 환자를 대상으로 한 AZD8359 STEAP2 TCE 초기 인간 임상시험
First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
리드: 아스트라제네카
- 1/2상모집 중· Alzheimer's Disease알츠하이머병 환자에서 피하 또는 정맥 주입을 통한 ABBV-1758의 안전성 및 효과 평가 연구
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
리드: 애브비
- 1/2상모집 중· Malignant Solid Tumors성인 고형 종양 환자에서의 TAK-505 임상시험
A Study of TAK-505 in Adults With Solid Tumors
리드: 다케다
- 1/2상모집 중· Lymphoma, Non-Hodgkin비호지킨림프종 환자에서 MK-1045의 임상시험(MK-1045-008)
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
리드: 머크(MSD)
- 1/2상모집 중· Lung Neoplasm MalignantA Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
리드: 머크(MSD)
- 1/2상모집 중· Advanced Prostate Cancer진행된 또는 전이성 전립선암 환자에서 GDC-1261의 안전성, 약동학, 예비 효과 평가 연구
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
리드: 로슈
- 1/2상모집 중· Locally Advanced or Metastatic Solid TumorsBC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
협력: 머크(MSD)
- 1/2상모집 중· Thoracic Neoplasms, Lung Diseases, Small Cell Lung CarcinomaA Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
협력: 로슈
- 1/2상모집 중· Advanced Solid Tumor CancerEarly-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors
리드: 바이오엔테크
- 1/2상모집 중· Oesophageal Squamous Cell CarcinomaA Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)
리드: 머크(MSD)
- 1/2상모집 중· Advanced Renal Cell Carcinoma (RCC)A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
리드: BMS · 협력: 바이오엔테크
- 1/2상모집 중· Relapsed Refractory Multiple Myeloma (RRMM)A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma
리드: 리제네론
- 1/2상모집 중· Recurrent Multiple MyelomaResponse-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma
협력: 리제네론
- 1/2상모집 중· Hepatocellular Carcinoma (HCC)A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
리드: BMS · 협력: 바이오엔테크
- 1/2상모집 중· Urothelial CancerSymbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
리드: 화이자
- 1/2상모집 중· Carcinoma, Non-Small-Cell LungA Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
리드: 얀센(J&J)
- 1/2상모집 중· Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaA Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-positive, HER2-negative, Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaUnresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
협력: 머크(MSD)
- 1/2상모집 중· Paroxysmal Nocturnal Hemoglobinuria (PNH)A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor
리드: 리제네론
- 1/2상모집 중· Relapsed/Refractory Small Cell Lung CancerA Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
리드: BMS
- 1/2상모집 중· Advanced/Metastatic Non-Small Cell Lung CancerSymbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
리드: 화이자
- 1/2상모집 중· Small Cell Lung Cancer Extensive StageA Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
리드: 머크(MSD)
- 1/2상모집 중· Gastrointestinal CancerA Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
협력: GSK
- 1/2상모집 중· Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
리드: 노바티스
- 1/2상모집 중· Advanced HR+/HER2- Breast CancerStudy of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
리드: 노바티스
- 1/2상모집 중· Bladder CancerA Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
리드: 머크(MSD)
- 1/2상모집 중· PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based ChemotherapyA Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
리드: 노바티스
- 1/2상모집 중· Carcinoma, HepatocellularSymbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
리드: 화이자
- 1/2상모집 중· Advanced or Metastatic Non-small Cell Lung CancerA Platform Study in Non-Small Cell Lung Cancer (NSCLC)
리드: 아스트라제네카
- 1/2상모집 중· Advanced or Metastatic Solid TumorsA Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
리드: 다케다
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.